Autotransfusion is a medical procedure in which the lost blood of a patient is collected and returned to the same patient. It should be considered in every trauma patient while in the emergency department. Autotransfusion can also be used in patients undergoing surgery or any patient with anticipated blood loss without contraindications. The global autotransfusion device market was valued at USD 1,147 million in 2021 to USD 1,327 million by 2028, progressing at a CAGR of 2.1% from 2022 to 2028, according to Gen Consulting Company.

The report provides in-depth analysis and insights regarding the current global market scenario, latest trends and drivers into global autotransfusion device market. It offers an exclusive insight into various details such as market size, key trends, competitive landscape, growth rate and market segments. This study also provides an analysis of the impact of the COVID-19 crisis on the autotransfusion device industry.

This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the product, application, end user, and region. The global market for autotransfusion device can be segmented by product: devices, accessories. Autotransfusion device market is further segmented by application: cardiac surgeries, orthopedic surgeries, organ transplantation, trauma procedures, others. Based on end user, the autotransfusion device market is segmented into: ambulatory surgery centers (ASCs), hospitals, specialty clinics. On the basis of region, the autotransfusion device market also can be divided into: Asia Pacific, Europe, North America, Rest of the World (RoW).

By product:
– devices
– accessories

By application:
– cardiac surgeries
– orthopedic surgeries
– organ transplantation
– trauma procedures
– others

By end user:
– ambulatory surgery centers (ASCs)
– hospitals
– specialty clinics

By region:
– Asia Pacific
– Europe
– North America
– Rest of the World (RoW)

The report explores the recent developments and profiles of key vendors in the Global Autotransfusion Device Market, including Advancis Surgical (Brightwake Limited), Atrium Medical Corporation (MAQUET Cardiovascular LLC), Fresenius SE & Co. KGaA, Haemonetics Corporation, LivaNova, PLC, Medtronic PLC, Stryker Corporation, Terumo Corporation, among others.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES

Historical & Forecast Period
This research report provides analysis for each segment from 2018 to 2028 considering 2021 to be the base year.

Scope of the Report
– To analyze and forecast the market size of the global autotransfusion device market.
– To classify and forecast the global autotransfusion device market based on product, application, end user, region.
– To identify drivers and challenges for the global autotransfusion device market.
– To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global autotransfusion device market.
– To identify and analyze the profile of leading players operating in the global autotransfusion device market.

Why Choose This Report
– Gain a reliable outlook of the global autotransfusion device market forecasts from 2022 to 2028 across scenarios.
– Identify growth segments for investment.
– Stay ahead of competitors through company profiles and market data.
– The market estimate for ease of analysis across scenarios in Excel format.
– Strategy consulting and research support for three months.
– Print authentication provided for the single-user license.